ADMA Biologics Ownership | Who Owns ADMA Biologics?


OverviewForecastRevenueFinancialsChartTranscripts

ADMA Biologics Ownership Summary


ADMA Biologics is owned by 85.93% institutional investors, 2.59% insiders, and 11.49% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 16.26% of ADMA shares. iShares Core S&P Small-Cap ETF is the top mutual fund, with 5.96% of its assets in ADMA Biologics shares.

ADMA Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockADMA Biologics85.93%2.59%11.49%
SectorHealthcare Stocks 279.17%10.51%-189.68%
IndustryBiotech Stocks 63.95%10.67%25.38%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock funding, inc. /de38.15M16.26%$654.27M
Blackrock18.64M8.15%$208.45M
Vanguard group18.20M7.76%$312.11M
State street14.87M6.34%$255.03M
Invesco11.30M4.82%$193.73M
Geode capital management5.43M2.32%$93.19M
Awm investment company5.10M2.23%$56.99M
Morgan stanley4.60M2.01%$51.41M
Dimensional fund advisors lp4.67M1.99%$80.07M
Nuveen asset management4.55M1.94%$78.07M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Stonepine capital management1.24M17.18%$21.28M
Awm investment company5.10M7.70%$56.99M
Ophir asset management pty1.34M3.43%$23.01M
Oberweis asset management inc/3.34M2.70%$57.32M
New millennium group214.31K2.15%$3.68M
First turn management684.23K2.10%$11.73M
Mesirow institutional investment management782.45K1.03%$13.42M
Perpetual3.63M0.73%$62.30M
Lisanti capital growth175.47K0.72%$3.01M
Clarivest asset management575.25K0.66%$6.43M

Top Buyers

HolderShares% AssetsChange
Perpetual3.63M0.73%3.63M
Allspring global investments2.84M0.08%2.61M
State street14.87M0.01%1.87M
Fmr3.20M0.00%1.25M
Raymond james financial1.11M0.01%1.11M

Top Sellers

HolderShares% AssetsChange
Assenagon asset management591.68K0.02%-2.88M
D. e. shaw3.07M0.04%-2.20M
Bank of montreal /can/26.56K0.00%-2.06M
Nuveen asset management4.55M0.02%-2.03M
Velan capital investment management lp---1.53M

New Positions

HolderShares% AssetsChangeValue
Perpetual3.63M0.73%3.63M$62.30M
Raymond james financial1.11M0.01%1.11M$19.08M
Tang capital management550.00K0.62%550.00K$9.43M
Royce & associates lp420.57K0.07%420.57K$7.21M
Simplify asset management385.19K0.33%385.19K$6.61M

Sold Out

HolderChange
Mendota financial group-4.00
Aquatic capital management-27.00
Ancora advisors-100.00
Reuter james wealth management-117.00
Abich financial wealth management-177.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 20253578.51%204,309,7520.18%851.14%192-4.00%1139.71%
Dec 31, 20243213.55%200,305,365-3.74%851.09%1961.55%992.06%
Sep 30, 202430920.23%208,056,49715.00%881.42%19329.53%9618.52%
Jun 30, 202425517.51%180,834,8813.64%791.33%1497.97%8053.85%
Mar 31, 202421716.67%174,477,0703.15%771.37%13850.00%52-10.34%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
iShares Core S&P Small-Cap ETF14.23M5.96%-7.29K
Vanguard US Total Market Shares ETF7.15M3.01%281.42K
Vanguard Total Stock Mkt Idx Inv6.42M2.69%69.59K
iShares Russell 2000 ETF5.88M2.46%2.88K
Vanguard Institutional Extnd Mkt Idx Tr3.65M1.53%20.35K
Xtrackers MSCI World Swap ETF 1C2.97M1.24%-
CREF Stock R12.80M1.20%-102.61K
SPDR® S&P Biotech ETF2.52M1.06%3.26K
Fidelity Small Cap Index2.29M0.96%63.24K
American Century U.S. Small Cap Growth2.17M0.91%189.57K

Recent Insider Transactions


DateNameRoleActivityValue
May 22, 2025Guiheen Lawrence P.-Sell$24.57K
May 21, 2025Guiheen Lawrence P.-Sell$158.07K
May 15, 2025Grossman Adam S President and CEOSell$116.70K
May 15, 2025Grossman Adam S President and CEOSell$291.75K
Apr 15, 2025Grossman Adam S President and CEOSell$321.90K

Insider Transactions Trends


DateBuySell
2025 Q2-6
2025 Q1-2
2024 Q4-2
2024 Q3-6
2024 Q2-1

ADMA Ownership FAQ


Who Owns ADMA Biologics?

ADMA Biologics shareholders are primarily institutional investors at 85.93%, followed by 2.59% insiders and 11.48% retail investors. The average institutional ownership in ADMA Biologics's industry, Biotech Stocks , is 63.95%, which ADMA Biologics exceeds.

Who owns the most shares of ADMA Biologics?

ADMA Biologics’s largest shareholders are Blackrock funding, inc. /de (38.15M shares, 16.26%), Blackrock (18.64M shares, 8.15%), and Vanguard group (18.2M shares, 7.76%). Together, they hold 32.17% of ADMA Biologics’s total shares outstanding.

Does Blackrock own ADMA Biologics?

Yes, BlackRock owns 8.15% of ADMA Biologics, totaling 18.64M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 208.45M$. In the last quarter, BlackRock increased its holdings by 445.43K shares, a 2.45% change.

Who is ADMA Biologics’s biggest shareholder by percentage of total assets invested?

Stonepine capital management is ADMA Biologics’s biggest shareholder by percentage of total assets invested, with 17.18% of its assets in 1.24M ADMA Biologics shares, valued at 21.28M$.

Who is the top mutual fund holder of ADMA Biologics shares?

iShares Core S&P Small-Cap ETF is the top mutual fund holder of ADMA Biologics shares, with 5.96% of its total shares outstanding invested in 14.23M ADMA Biologics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools